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Abstract
This study investigated the effects of AdipoRon, which is an agonist for adiponectin receptor
1 (AdipoR1) and AdipoR2, on the protein content, myotube diameter, and number of nuclei
per myotube of C2C12 cells and skeletal muscle mass in C57BL/6J mice. AdipoRon sup-
pressed the protein content, myotube diameter, and number of nuclei per myotube of C2C12
cells of C2C12 myotubes in a dose-dependent manner. Adiponectin-associated decline of
protein content, diameter, and number of nuclei per myotube in C2C12 myotubes was par-
tially rescued by knockdown of AdipoR1 and/or AdipoR2. Phosphorylation level of AMPK
showed a trend to be increased by AdipoRon. A significant increase in phosphorylation level
of AMPK was observed at 20 μM AdipoRon. Knockdown of AdipoR1 and/or AdipoR2 res-
cued AdipoRon-associated decrease in protein content of C2C12 myotubes. AdipoRon-
associated increase in phosphorylation level of AMPK in C2C12 myotubes was suppressed
by knockdown of AdipoR1 and/or AdipoR2. Successive intravenous injections of AdipoRon
into mice caused a decrease in the wet weight of plantaris muscle (PLA), but not in soleus
muscle (SOL). Mean fiber cross-sectional area of PLA, but not of SOL, was significantly
decreased by AdipoRon administration. On the one hand, the expression level of phosphory-
lated AMPK and ubiquitinated protein in SOL and PLA muscles was upregulated by Adi-
poRon administration. On the other hand, AdipoRon administration induced no changes in
the expression level of puromycin-labeled proteins in both SOL and PLA muscles. Expres-
sion level of adiponectin in extensor digitorum longus (EDL) muscle was increased by aging,
but not in SOL muscle. Aging had no effect on the expression level of AdipoR1 and AdipoR2
in both muscles. Phosphorylation level of AMPK in EDL was increased by aging, but not SOL
muscle. Results from this study suggest that high level of circulating adiponectin may induce
skeletal muscle atrophy, especially fast-type muscle.
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Introduction
Skeletal muscle has a large plasticity. Skeletal muscle mass as well as function adapts to various
extracellular and intracellular stimuli. Skeletal muscle atrophy is induced by inactivity, unload-
ing, malnutrition as well as several diseases, including cancer, diabetes and heart failure [1,2].
Sarcopenia is well known as an aging-associated decline in skeletal muscle weakness accompa-
nied with mass loss and dysfunction, resulting in impaired physical function [3]. Reduced
physical function leads to physical inactivity that induces obesity, osteoporosis, frailty, and
other various life style-related diseases [4]. Therefore, the maintaining of skeletal muscle mass
and function is a priority task in most countries with increasing populations have increasing
percentages of large shares of adults aged 65 years and older, due to rising health-care cost
[5,6]. However, the molecular mechanisms for aging-associated reductions in skeletal muscle
mass remains unclear.
Basic experiments revealed that adiponectin is an adipocytokine that have various anti-
pathophysiological action such as insulin sensitization, anti-inflammatory, stimulating effects
of energy utilization, and so on. Adiponectin, which is synthesized and is secreted by adipo-
cytes, induces physiological functions in targeted tissues and cells via adiponectin receptors
(AdipoRs) [7,8]. Skeletal muscle, which is a main target tissue for adiponectin, expresses high
level of AdipoR1 and low level of AdipoR2, which is main expressing form of hepatocytes [9].
Recently, there are several epidemiological studies regarding negative relationship between
circulating adiponectin level and mortality rate as well as various clinical conditions, so-called
“adiponectin paradox” [10,11]. For instance, circulating level of adiponectin is negatively cor-
related with skeletal muscle mass as well as force [12,13,14]. However, there are no experimen-
tal evidence showing the effects of elevated blood adiponectin level on skeletal muscle mass.
Not only AdipoRs but also adiponectin itself expresses in skeletal muscle cells [15,16]. In
addition, it is suggested that skeletal muscle cells themselves synthesize and may secrete adipo-
nectin in an autocrine- and/or paracrine-manner [15]. If high level of adiponectin may impact
on skeletal muscle mass, the expression level of adiponectin and/or AdipoRs in skeletal muscle
also could be a key factor to regulate skeletal muscle mass. There is no evidence regarding
aging-associated changes in the expression level of adiponectin and AdipoRs in skeletal
muscles.
Skeletal muscle mass is regulated by a dynamic balance between protein synthesis and pro-
teolysis. Hypertrophic stimuli such as mechanical stretch, cause to increase in protein synthe-
sis, resulting the increase in muscle protein and mass, which is namely muscle hypertrophy
[17,18]. On the other hand, unloading stimulates proteolysis in skeletal muscle cells, and
induces the decline of muscle protein and mass, namely muscle atrophy [1,15,19]. Although
there are many evidences regarding the dose-dependent effects of adiponectin on insulin sen-
sitivity and AMP-dependent protein kinase (AMPK) that is activated by adiponectin [20,21],
the effect of various concentration of adiponectin on protein synthesis and proteolysis in skele-
tal muscles remain unclear.
Therefore, in this study, we investigated the administration of AdipoR agonist AdipoRon
on muscle mass using cultured skeletal muscle cells and adult mouse skeletal muscles to clarify
whether a high level of adiponectin induces skeletal muscle atrophy or not. Effects of aging on
the expression level of adiponectin and AdipoRs in mouse skeletal muscles were also
investigated.
Materials and methods
Mouse myoblast-derived cell-line C2C12 was used in the cell culture experiment. All animal
protocols were carried out in accordance with the Guide for the Care and Use of Laboratory
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Animals as adopted and promulgated by the National Institutes of Health (Bethesda, MD) and
were approved by the Animal Use Committee at Toyohashi SOZO University (A2014002,
A2015002, A2016004, A2017007). All treatments of animals were performed under anesthesia
with i.p. injection of sodium pentobarbital, and all efforts were made to prevent discomfort
and suffering. Young (10-week old) and old (100-week-old) male C57BL/6J mice were used.
All mice were housed in a vivarium room with 12:12-h light:dark cycle and a maintained tem-
perature and humidity of ~23˚C and ~50%, respectively. Solid food and water were provided
ad libitum.
Cell culture experiments
C2C12 myoblasts were cultured on culture plates coated with a genetic type I collagen (Bio-
Coat, 12 wells, Corning, NY). Cells were grown in the growth medium consisting of Dulbec-
co’s modified Eagle’s medium (DMEM) supplemented with 10% heat-inactivated fetal bovine
serum containing high glucose (4,500 mg glucose/L) in a humidified atmosphere of 95% air
and at 37˚C in 5% CO2 for 24 h (~80% confluent).
RNA interference. Twenty-four hours after the seeding, RNA oligos were transfected into
myoblasts using LipofectamineTM RNAiMAX Transfection Reagent (Thermo Fisher Scientific,
Waltham, MA) according the manufacturer’s instructions. Details for the transfection of
sRNA was described previously [22]. Briefly, lipofectamine/siRNA complexes were added the
growth medium, and myoblasts were incubated for 24 h. The final concentration of siRNA
was set at 5 nM in a single knockdown of AdipoR1 or AdipoR2 and 10 nM in a double knock-
down of AdipoR1 and AdipoR2, respectively. Following 24-h incubation, the transfection
medium was changed with the differentiation medium consisting of DMEM supplemented
with 2% horse serum containing low glucose (1,000 mg/L glucose). The culture medium was
then changed to a differentiation medium. Differentiation medium was exchanged every other
day.
The siRNA oligonucleotides designed against mouse adiponectin receptor 1 (siAdipoR1:
targeting sequence 5’-CAGGGATTGCTCTACTGATTA-3’), siAdipoR2 (targeting sequence
5’-CAGGCCCATCATGCTATGGAA-3’), and scrambled non-targeting control siRNA (siS-
cramble: All Stars Negative Control siRNA) were obtained from Qiagen (Hiden, Germany).
Knockdown efficiency of each siRNA was checked using Real-time RT-PCR. mRNA Expres-
sion level of for AdipoR1 and/or AdipoR2 was decreased by approximately 76~90% (S1 Fig).
Positive control experiment was also carried out using siRNA for glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) supplied by Thermo Fisher Scientific (4390849: SilencerTM Select
GAPDH Positive Control siRNA). GAPDH mRNA was decreased by ~90% in the knockdown
procedure in this experiment using siRNA (S2 Fig).
AdipoRon treatment. We investigated the effects of AdipoRon (AdipoGen Life Sciences,
San Diego, CA), instead of adiponectin, on C2C12 myotubes. AdipoRon binds AdipoRs, and
induces adiponectin-associated physiological functions via AMPK-associated intracellular sig-
naling [20,23]. Five days after the initiation of differentiation, AdipoRon was added to the dif-
ferentiation medium. C2C12 myotubes were incubated with AdipoRon for 36 h. AdipoRon
was dissolved in dimethyl sulfoxide (DMSO). Final concentrations of AdipoRon in the
medium was set at 0, 5, 10, and 20 μM. After 36 h-incubation of AdipoRon, cells were
collected.
Animal experiments
Effects of AdipoRon administration on mouse skeletal muscles. We investigated the
effects of AdipoRon administration on skeletal muscle mass in C57BL/6J male mice (10-week
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old). Mice were divided into 2 groups; control (n = 7) and AdipoRon-administrated (n = 5)
groups.
AdipoRon (50 mg/kg body weight) was dissolved in DMSO (0.75 μl/g body weight), and
was injected into caudal vein of mice in the AdipoRon-administrated group, in accordance
with the previous study [23]. Although we did not evaluate the serum concentration of Adi-
poRon, this amount of AdipoRon could induce various physiological actions similar to adipo-
nectin [23]. AdipoRon was injected once a day, 3 days a week, for 4 weeks. DMSO (0.75 μl/g
body weight) was injected into mice of the control group. Three days after the final injection,
soleus (SOL) and plantaris (PLA) muscles were dissected from both hindlimbs of mice in both
groups. Muscles were trimmed of excess fat and connective tissues, weighed, frozen in liquid
nitrogen, and stored at −80˚C.
Expression level of adiponectin and its receptor in skeletal muscles in young and old
mice. We also investigated the effects of age on skeletal muscle mass in young (10-week old,
n = 5) and old (100-week old, n = 5) C57BL/6J male mice. SOL and extensor digitorum longus
(EDL) muscles were dissected from both hindlimbs of young and old mice. Muscles were
trimmed of excess fat and connective tissues, weighed, frozen in liquid nitrogen, and stored at
−80˚C.
Sample preparation
In the cell culture experiments, sample preparation was performed with the previously
reported method [15,22]. Briefly, the cells in each well were scraped off into 0.15 ml of the lysis
buffer that consists of CelLyticTM-M cell lysis reagent (Sigma, St. Louis, MO) with 1% (v/v)
protease/protease inhibitor cocktail (Cell Signaling Technology, Danvers, MA). The cell lysate
was sonicated and centrifuged at 15,000 g at 4˚C for 15 min. Then, the supernatant was
collected.
In the animal experiments, the frozen muscle samples were homogenized in 5 volumes of
the lysis buffer with glass homogenizer as described as previously [15]. The homogenate was
centrifuged at 15,000 g at 4˚C for 15 min. The supernatant was collected.
Protein content of the supernatant from both cells and skeletal muscles was evaluated using
the Bradford technique (protein assay kit; Bio-Rad with bovine serum albumin (Sigma) as the
standard [15,22].
Evaluation of protein synthesis
Surface sensing translation (SUnSET) is a nonradioactive method to monitor and quantifica-
tion of global protein synthesis in mammalian cells [24]. Briefly, 30 min before sampling, mice
were injected intraperitoneally with puromycin (0.04 μmol/g) dissolved in 100 μl of phos-
phate-buffered saline under anesthesia. The expression of puromycin-labeled proteins was
analyzed by Western blot analyses as described below.
Evaluation of proteolysis
In the present study, the proteolysis in skeletal muscle was evaluated the expression level of
ubiquitinated proteins using Western blot analyses as described below.
Western blot analysis
Western blot analysis was performed, as was described previously [15,22]. Extracted samples in
the cell lysis reagents were solubilized in Laemmli’s sample buffer and boiled for 5 min. The
samples were separated by SDS-PAGE using 10 or 15% polyacrylamide gel at a constant current
Activation of adiponectin receptors and muscle atrophy in C2C12 myotubes and fast-type mouse skeletal muscle
PLOS ONE | https://doi.org/10.1371/journal.pone.0205645 October 11, 2018 4 / 18
of 20 mA/gel for 90 min. Bio-Rad Precision Markers (Bio-Rad Laboratories, Hercules, CA)
were applied to both sides of gel as the internal controls for transfer process or electrophoresis.
After SDS-PAGE, the proteins were transferred to polyvinylidene fluoride membranes
(Hybond-P, GE Healthcare, Buckinghamshire, UK) by using trans-blot cell (Bio-Rad) at a con-
stant voltage of 100 V for 1 h at 4˚C. After the transfer, the membranes were blocked for 1 h
using ECL blocking reagent (RPN418, GE Healthcare). For the analyses on the expression
level of ubiquitin- and puromycin-labeled proteins, the membranes were stained with Ponceau
S solution (Sigma). Then, the membranes were incubated over night at 4˚C with primary anti-
body [adiponectin (ab22554, Abcam, Cambridge, UK), AdipoR1 (GTX104770, GeneTex,
Irvine, CA), AdipoR2 (14361-1-AP, Proteintech, Rosemont, IL), AMPKα Thr172 (2531, Cell
Signaling Technology), AMPK (2532, Cell Signaling Technology), ubiquitin (SPA-200, Enzo
Life Sciences, NY), puromycin (MABE343, Merck, Darmstadt, Germany), glyceraldehyde
3-phosphate dehydrogenase (GAPDH: 2118, Cell Signaling Technology) and β-actin (4967,
Cell Signaling Technology)]. The membranes were then washed with Tris-buffered saline with
0.1% Tween 20 (TBS-T, pH 7.5) and reacted with anti-rabbit IgG (7074, Cell Signaling Tech-
nology), anti-mouse IgG (7076, Cell signaling Technology) or anti-mouse IgG2a (ab98698,
abcam) for 1h at room temperature. After the final wash with TBS-T, protein bands were visu-
alized using chemiluminescence (GE Healthcare), and signal density was measured using
Light-Capture (AE-6971, ATTO Corporation, Tokyo, Japan) with ImageJ software (National
Institutes of Health, MD).
Real-time RT-PCR analysis
Real-time RT-PCR analysis was performed, as was described previously [15,21]. Briefly, total
RNA was extracted from muscles using the miRNeasy Mini kit (Qiagen) according to the man-
ufacturer’s protocol. For the detection of AdipoR1 and AdipoR2, the RNA was reverse-tran-
scribed to cDNA using PrimeScript RT Master Mix (Takara Bio, Otsu, Japan), and then
synthesized cDNA was applied to real-time RT-PCR (Thermal Cycler Dice Real Time System
IIMRQ, Takara Bio) using Takara SYBR Premix Ex Taq II (Takara Bio). Relative fold change
of expression was calculated by the comparative CT method with Takara Thermal Cycler Dice
Real Time System Software Ver. 4.00. To normalize the amount of total RNA present in each
reaction, GAPDH for AdipoR1 and AdipoR2 were used as an internal standard.
Following primers were used: adiponectin, 5’-TTCTGTCTGTACGATTGTCAGTGG-3’
(forward) and 5’-GTCATCTTCGGCATGACTGG-3’ (reverse), AdopoR1, 5’-CTGGGC
ATCTCTGCCATCA-3’ (forward) and 5’-CTTGACAAAGCCCTCAGCGATA-3’ (reverse);
AdipoR2, 5’-ATCAGCAGCCAGACGACTC-3’ (forward) and 5’-TGACCAGTCCCAAAGA
CCTCTACTC-3’ (reverse); GAPDH, 5’-TGTGTCCGTCGTGTGGATCTGA-3’ (forward)
and 5’-TTGCTGTTGAAGTCGCAGGAG-3’ (reverse).
Morphological analyses of myotubes
Myotube diameter was evaluated as described earlier [22]. Briefly, 4 fields were chosen ran-
domly, and 150 myotubes were measured using ImageJ. The average diameter per myotube
was calculated as the mean of three short-axis measurements taken along the length of the
myotube. To evaluate differentiation level of myotubes, the number of nuclei per myotube was
also investigated.
Histochemical and immunohistochemical analyses
Serial transverse cryosections (7-μm thick) of frozen distal portion of SOL and PLA muscles
were cut at -20 oC and mounted on the slide glasses. The sections were air-dried and stained to
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analyze the degree of muscle damage and repair and the cross-sectional area (CSA) of muscle
fibers by staining using hematoxylin and eosin (H&E) [25,26].
Statistical analyses
All values were expressed as means ± SEM. Statistical significance was analyzed by using two-
way ANOVA followed by post hoc comparison with Tukey’s test (Figs 1B, 2 and 3).
Fig 1. Effects of AdipoRon administration on C2C12 myotubes with or without knockdown of adiponectin receptor (AdipoR). Final concentration of AdipoRon
was set at 0, 5, 10 and 20 μM in the differentiation medium. A: Effects of AdipoRon on C2C12 myotubes morphology with or without AdipoR knockdown. B: Effects
of AdipoRon on protein content in C2C12 myotubes with or without AdipoR knockdown. siScramble: scrambled non-targeting control siRNA, siAdipoR1: siRNA for
AdipoR1, siAdipoR: siRNA for AdipoR2, siAdipoR1+R2: siRNA for AdipoR1 and AdipoR2. n = 5 in each condition of each treated cells. Values are expressed means
with SEM. �: p<0.05. Significant level of main effects was analyzed by two-way ANOVA (concentration x treatment).
https://doi.org/10.1371/journal.pone.0205645.g001
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Differences in the body weight, absolute and relative muscle wet weights (Fig 4), mean fiber
CSA (Fig 5), the expression level of puromycin- and ubiquitin-labeled proteins (Fig 6), and the
phosphorylation level of AMPK (Fig 7) were analyzed by using Student’s t-test. Deference in
the muscle weights between young and aged mice (Fig 8) was also analyzed using Student’s t-
test. Data in Figs 9 and 10 were analyzed by using two-way ANOVA followed by post hoc com-
parison with Tukey’s test. Data in S1 and S2 Figs were analyzed by one-way ANOVA followed
by post hoc comparison with Tukey’s test. The differences between groups were considered
statistically significant at p<0.05.
Results
Effects of AdipoRon on C2C12 myotubes
Fig 1 shows the effects of AdipoRon on C2C12 myotubes. Diameter and fusion index of myo-
tubes was decreased by AdipoRon (Fig 2). However, knockdown of AdipoR1 and/or AdipoR2
partially rescued AdipoRon-associated changes of myotubes.
Fig 2. Effects of AdipoRon administration on myotube diameter and number of nuclei per myotube of C2C12 cells with or without knockdown of
adiponectin receptor (AdipoR). Final concentration of AdipoRon was set at 0, 5, 10 and 20 μM in the differentiation medium. A: Effects of AdipoR
knockdown on myotube diameter at 0 μM AdipoRon. B: Effects of AdipoRon on the relative myotube diameter with or without AdipoR knockdown. C: Effects
of AdipoR knockdown on the number of nuclei per myotube at 0 μM AdipoRon. D: Effects of AdipoRon on the relative number of nuclei per myotube with or
without AdipoR knockdown. Abbreviations are the same as in Fig 1. Values are expressed means with SEM. �: p<0.05. Significant level of main effects was
analyzed by two-way ANOVA (concentration x treatment).
https://doi.org/10.1371/journal.pone.0205645.g002
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AdipoRon treatment decreased muscle protein content in a dose-dependent manner (Fig
1B; effect of concentration, p<0.05). Muscle protein content at 20 μM AdipoRon was signifi-
cantly lower than that at 0, 5, and 10 μM AdipoRon (p<0.05, Fig 1B). AdipoRon-associated
decrease in muscle protein content was partially rescued by knockdown of AdipoR1 and/or
AdipoR2 (Fig 1B; effect of treatment, p<0.05). There was a significant difference in muscle
protein content between siScramble and targeting siRNA for AdipoR (siAdipoR1 and/or Adi-
poR2, p<0.05).
Myotube diameter and number of nuclei per myotube was also suppressed by AdipoRon in
as dose-dependent manner (Fig 2B and 2D; effect of concentration, p<0.05). In the present
study, on the other hand, knockdown of AdipoR had no impact on both indexes (Fig 2A and
2C). AdipoRon-associated decrease in myotube dimeter and number of nuclei per myotube
was partially rescued by knockdown of AdipoR1 and/or AdipoR2 (Fig 2B and 2D; effect of
treatment, p<0.05). At 20 μM AdipoRon, there were significant differences in myotube diame-
ter between siScramble and targeting siRNA for AdipoR (siAdipoR1 and/or AdipoR2,
p<0.05).
AMPK is a downstream of adiponectin-AdipoR-associated signaling pathway [20,21], and
is also known as a negative regulator for skeletal muscle mass [27]. Therefore, we investigated
the effects of AdipoRon on phosphorylation level of AMPK in C2C12 myotubes.
Fig 3. Effects of AdipoRon on phosphorylation level of AMP-dependent protein kinase (AMPK) with or without knockdown of adiponectin receptor
(AdipoR). Abbreviations are the same as in Fig 1. n = 5 in each condition of each treated cells. Values are expressed means with SEM. �: p<0.05. Significant
level of main effects was analyzed by two-way ANOVA (concentration x treatment).
https://doi.org/10.1371/journal.pone.0205645.g003
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Phosphorylation level of AMPK showed a trend to be increased by AdipoRon (Fig 3). A signif-
icant increase in phosphorylation level of AMPK was observed at 20 μM AdipoRon, but not at
5 and 10 μM AdipoRon. Knockdown of AdipoR1 and/or AdipoR2 suppressed AdipoRon-
associated upregulation of AMPK phosphorylation in C2C12 myotubes.
Effects of AdipoRon administration on mouse skeletal muscles
Since the cell-culture experiments suggested that high concentration of AdipoRon causes to
decrease in muscle mass, we investigated the effects of AdipoRon administration on mouse
skeletal muscle mass in vivo. Successive intravenous injections of AdipoRon into mice caused
a decrease in the absolute and relative muscle wet weights of PLA muscle (p<0.05), but not of
SOL muscle, compared with the vehicle-control group (Fig 4B and 4C). However, there was
no significant change in body weight (Fig 4A). Representative H&E images of SOL and PLA
Fig 4. Effects of AdipoRon administration on mouse skeletal muscles. A: Body weight, B: absolute muscle wet weight of soleus (SOL) and plantaris (PLA) muscles, C:
muscle wet weight relative to body weight. CON: vehicle-control group, Adipo: AdipoRon-administrated group, n = 7 and 5 in vehicle-control and AdipoRon-
administrated groups, respectively. Values are means with SEM. �: p<0.05.
https://doi.org/10.1371/journal.pone.0205645.g004
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muscles were shown in Fig 5A. Mean fiber CSA in PLA muscle, but not in SOL muscle, was
significantly decreased by AdipoRon administration (Fig 5B).
Then, we evaluated the levels of protein synthesis and proteolysis in SOL and PLA muscles
using SUnSET method and ubiquitinated protein level, respectively (Fig 6A and 6B). A trend
to suppress protein synthesis in AdipoRon-administrated PLA and SOL muscles was observed.
However, AdipoRon administration had no significant effect on protein synthesis of both
Fig 5. Effects of AdipoRon administration on fiber cross-sectional area (fiber CSA) of mouse skeletal muscles. A:
representative images of H&E stained cross-sections of soleus (SOL) and plantaris (PLA) muscles, B: mean fiber CSA of SOL and
PLA muscles. Abbreviations are the same as in Fig 4. n = 3. Values are means with SEM. �: p<0.05.
https://doi.org/10.1371/journal.pone.0205645.g005
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muscles. On the other hand, ubiquitinated protein expression in both muscles was significantly
upregulated by AdipoRon administration (p<0.05, Fig 6B). We also investigated the effects of
AdipoRon on phosphorylation level of AMPK in SOL and PLA muscles in mice. Phosphoryla-
tion level of AMPK in both muscles was significantly increased by AdipoRon administration
(Fig 7).
Expression level of adiponectin and its receptor in skeletal muscles in
young and old mice
We investigated the effects of aging on the expression level of adiponectin and AdipoRs in
mouse skeletal muscle. Both muscle weights were significantly decreased by aging (Fig 8,
p<0.05). Basal expression level of adiponectin in SOL muscle was significantly higher than
that in EDL muscle in young and old mice (p<0.05, Fig 9A). A significant aging-associated
upregulation of adiponectin was observed in EDL muscle (p<0.05), but not in SOL muscle.
Fig 9B and 9C show the expression level of AdipoR1 and AdipoR2 in SOL and EDL in
young and old mice, respectively. In young mice, the expression level of AdipoR1 in EDL mus-
cle was significantly higher than that in SOL muscle (p<0.05). On the other hand, there was
Fig 6. Effects of AdipoRon administration on the expression level of puromysin-labeled and ubiquitinated proteins in mouse skeletal muscles. A:
Expression level of puromysin-labeled proteins, B: Expression level of ubiquitinated proteins. Ponceau staining was applied for the loading and blotting control
of Western blotting analyses. Abbreviations are the same as in Fig 4. n = 7 and 5 in vehicle-control and AdipoRon-administrated groups, respectively. Values
are means with SEM. �: p<0.05.
https://doi.org/10.1371/journal.pone.0205645.g006
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no significant difference in the expression level of AdipoR2 between SOL and EDL muscles.
Aging-associated increase in the expression level of AdipoR1 was observed in SOL muscle
(p<0.05), but not in EDL muscle. On the contrary, a significant decrease in the expression
level of AdipoR2 was observed in both muscles (p<0.05). We also investigated the effects of
aging on phosphorylation level of AMPK in SOL and EDL muscles in mice. In young mice,
the phosphorylation level of AMPK in SOL muscle was significantly higher than that in EDL
muscle (p<0.05). Phosphorylation level of AMPK in EDL muscles was significantly increased
by aging, but not in SOL muscle (Fig 10).
Discussion
This study investigated the effects of AdipoRon on the protein content of C2C12 myotubes
and mouse muscle mass of slow SOL and fast PLA. AdipoRon suppressed the protein content,
myotube diameter and number of nuclei per myotube of C2C12 cells in a dose-dependent
manner via upregulation of phosphorylated AMPK. Adiponectin-associated decline of the
protein content, myotube diameter and number of nuclei per myotube of C2C12 cells was par-
tially rescued by knockdown of AdipoR1 and/or AdipoR2. Successive intravenous injections
Fig 7. Effects of AdipoRon administration on phosphorylation level of AMP-dependent protein kinase (AMPK)
in mouse skeletal muscles. Abbreviations are the same as in Fig 4. n = 7 and 5 in vehicle-control and AdipoRon-
administrated groups, respectively. Values are means with SEM. �: p<0.05.
https://doi.org/10.1371/journal.pone.0205645.g007
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of AdipoRon into mice caused a decrease in the wet weight of PLA muscle, but not in SOL
muscle. However, phosphorylation level of AMPK in PLA and SOL muscles was increased by
AdipoRon administration. On the one hand, basal expression level of adiponectin in mouse
slow SOL muscle was significantly higher than that in fast EDL muscle. On the other hand, the
expression level of adiponectin in fast EDL muscle was lower than slow SOL muscle. Further-
more, the expression level of adiponectin and phosphorylated AMPK in EDL muscle was
increased by aging, but not in SOL muscle. Aging had no impact on the expression level of
AdipoR1 and AdipoR2 expression levels in both muscles.
This study demonstrated that AdipoRon administration caused a loss of muscle protein
content, myotube diameter and number of nuclei per myotube of C2C12 cells as well as muscle
wet weight and fiber CSA in mouse fast PLA muscle. This is the first study regarding the nega-
tive effects of AdipoRon on C2C12 myotubes as well as mouse fast-type skeletal muscle. Previ-
ous study showed globular adiponectin stimulated myogenic differentiation of C2C12
myoblasts under a starved condition that is serum-free growth medium [28]. Under starved
condition, C2C12 myoblasts did not differentiate into myotubes [28]. In the present study, on
the other hand, the effects of AdipoR agonist on C2C12 myotubes incubated with differentia-
tion medium containing 2% horse serum. The differences in the culture conditions and/or in
the timing of AdipoRon chemical may cause a conflict between 2 studies.
In the present study, knockdown of AdipoR1 and/or AdipoR2 partially rescued AdipoRon-
associated decrease in the protein content, myotube diameter and number of nuclei per myo-
tube of C2C12 cells. On the other hand, the phosphorylation level of AMPK was also depressed
by knockdown of AdipoR1 and/or AdipoR2. It is also reported that globular adiponectin upre-
gulated phosphorylated AMPK in C2C12 myoblasts [28]. Phosphorylated AMPK, which is
active form, suppressed muscle protein content and myogenic differentiation of C2C12 cells
[20]. In this study, AdipoRon administration also upregulated ubiquitinated protein level in
mouse skeletal muscles. In addition, AdipoRon had no significant impact on protein synthesis
in mouse skeletal muscles. Therefore, AdipoRon-associated decrease in muscle mass may
induce by the enhanced proteolysis via activation of AdipoRs-AMPK signaling pathway.
Fig 8. Muscle wet weight in soleus (SOL) and extensor digitorum longus (EDL) muscles of young and old mice.
Young: 10-week old mice, old: 100-week old mice. n = 5 in each aged group of mice. Values are expressed means with
SEM. �: p<0.05.
https://doi.org/10.1371/journal.pone.0205645.g008
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Recently, a negative correlation between circulation level of adiponectin and muscle mass
as well as and physical functioning in the elderly people, so-called adiponectin paradox, has
been reported [12,13,14]. However, these reports are based on the epidemiologic cross-sec-
tional studies. There were no experimental evidences regarding high level of adiponectin-asso-
ciated skeletal muscle atrophy, namely adiponectin paradox in skeletal muscle. The present
study demonstrated the first experimental evidences that the successive intravenous injection
of AdipoRon into mice induces skeletal muscle atrophy. This phenomenon may be the first
experimental evidence indicating “adiponectin paradox” in skeletal muscle. Since serum level
of adiponectin is low in obesity, compared with non-obesity healthy people [2], it has been
generally accepted that a high level of serum adiponectin gives us various benefits for our
health, and has a preventive effect against life style-associated diseases [16,29]. However, a
high level of serum adiponectin may impair skeletal muscle function.
In this study, AdipoRon-associated atrophy was observed in fast PLA muscle, but not in
slow SOL muscle. There was no difference in AdipoRon-associated changes in proteolysis and
protein synthesis of both type of muscles. Furthermore, phosphorylation level of AMPK in
both muscles was also increased by AdipoRon. The molecular mechanism underlaying muscle
type-dependent responses to AdipoRon remains unclear. We have no clear explanation
Fig 9. Expression level of adiponectin and adiponectin receptors in soleus (SOL) and extensor digitorum longus (EDL) muscles of young and old mice. A:
adiponectin, B: adiponectin receptor 1 (AdipoR1), C: adiponectin receptor 2 (AdipoR2). Other abbreviations are the same as in Fig 5. n = 5 in each aged group
of mice. Values are expressed means with SEM. �: p<0.05. Significant level of main effects was analyzed by two-way ANOVA (age x muscle).
https://doi.org/10.1371/journal.pone.0205645.g009
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regarding this discrepancy at present. Other proteolytic systems such as autophagy or calpain
pathway might be involved in AdipoRon-associated fast type-specific skeletal muscle atrophy.
This study showed that the basal expression level of adiponectin in fast EDL muscle
was lower than slow SOL muscle. Furthermore, aging-associated upregulation of adipo-
nectin expression was observed in EDL muscle, but not in SOL muscle. On the other
hand, there was no significant difference in aging-associated changes in AdipoRs expres-
sion level in both muscles. This is the first study showing muscle type-dependent differ-
ence in the expression level of adiponectin, and aging-associated upregulation of
adiponectin in fast EDL muscle. It is suggested that inflammation upregulates adiponec-
tin in skeletal muscle [16,29]. A possibility of inflammation in fast skeletal muscle, but
not in slow muscle, might increase with aging.
Since skeletal muscle cells themselves synthesize and may secrete adiponectin in an auto-
crine- and/or paracrine-manner [15], the expression level of adiponectin in skeletal muscle
might impact on skeletal muscle mass. In the present study, we observed aging-associated acti-
vation of AMPK in fast EDL muscle, but not slow SOL muscle. These results are consistent
with the previous study [30]. Therefore, aging-associated upregulation of adiponectin in fast
skeletal muscle may explain the molecular mechanism for sarcopenia, in part. Additional
investigations are needed to elucidate this issue.
Fig 10. Phosphorylation level of AMP-dependent protein kinase (AMPK) in soleus (SOL) and extensor digitorum longus (EDL) muscles of young
and old mice. A: adiponectin, B: adiponectin receptor 1 (AdipoR1), C: adiponectin receptor 2 (AdipoR2). Other abbreviations are the same as in Fig 9.
n = 5 in each aged group of mice. Values are expressed means with SEM. �: p<0.05. Significant level of main effects was analyzed by two-way ANOVA
(age x muscle).
https://doi.org/10.1371/journal.pone.0205645.g010
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Conclusion
AdipoRon caused a decrease in muscle protein content, myotube diameter and number of
nuclei per myotube of C2C12 cells in a dose-dependent manner via AdipoRs-AMPK signaling
pathway. Decrease in the wet weight of fast PLA muscle, but not in slow SOL muscle, was also
induced by the successive administrations of AdipoRon into mice. Results from this study
indicate that high level of circulating adiponectin may induce atrophy of fast type muscle.
Aging-associated upregulation in skeletal muscle-specific adiponectin might be also involved
in aging-associated skeletal muscle atrophy, namely sarcopenia.
Supporting information
S1 Fig. Knock-down efficiency of siRNA for adiponectin receptors (AdipoRs). A: Effects of
single knockdown of AdipoR1 on AdipoR1 mRNA, B: Effects of single knockdown of Adi-
poR2 on AdipoR2 mRNA, C: Effects of double knockdown of AdipoR1 and AdipoR2 on Adi-
poR1 mRNA, D: Effects of double knockdown of AdipoR1 and AdipoR2 on AdipoR2 mRNA.
Control: untreated control cells, mock-transfection: cells were treated with transfection
reagents without siRNA, siScramble: scrambled non-targeting control siRNA, targeting
siRNA: siRNA for AdipoR1 and/or AdipoR2. n = 5 in each condition of each treated cells. Val-
ues are expressed means with SEM. �: p<0.05.
(TIF)
S2 Fig. Knock-down efficiency of positive control siRNA for glyceraldehyde 3-phosphate
dehydrogenase (GAPDH). Abbreviations are the same as in S1 Fig. n = 5 in each condition of
each treated cells. Values are expressed means with SEM. �: p<0.05.
(TIF)
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